Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo

Journal of Cerebral Blood Flow and Metabolism

Volumn 23, Issue 3, 2003, Pages 342-354

  Faden, Alan I ^a   Knoblach, Susan M ^a   Cernak, Ibolja ^a   Fan, Lei ^a   Vink, Robert ^a   Araldi, Gian Luca ^a   Fricke, Stanley T ^a   Roth, Bryan L ^b   Kozikowski, Alan P ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Necrosis; Neuroprotection; Traumatic brain injury; TRH analogs

Indexed keywords

MAITOTOXIN; PIPERAZINEDIONE; PROTIRELIN DERIVATIVE; STAUROSPORINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INJURY; COGNITION; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; GLIA; IN VITRO STUDY; IN VIVO STUDY; MOTOR ACTIVITY; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NEWBORN; NICK END LABELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STRUCTURE ANALYSIS;

EID: 0037341527     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wcb.0000046143.31247.fd     Document Type: Article

References (55)

1. Albensi BC, Knoblach SM, Chew BG, O'Reilly MP, Faden AI, Pekar JJ (2000) Diffusion and high resolution MRI of traumatic brain injury in rats: time course and correlation with histology. Exp Neurol 162:61-72
2. Allen JW, Knoblach SM, Faden AI (1999) Combined mechanical trauma and metabolic impairment in vitro induces NMDA receptor-dependent neuronal cell death and caspase-3-dependent apoptosis. FASEB J 13:1875-1882
3. Andrews JS, Sahgal A (1983) Central administration of thyrotropin-releasing hormone and histidyl-proline-diketopiperazine disrupts the acquisition of a food rewarded task by a non-aversive action. Regul Pept 7:373-383
4. Andrews JS, Sahgal A (1984) The effects of thyrotropin-releasing hormone on a visual discrimination task in rats. Pharmacol Biochem Behav 21:715-719
5. Bassiri RM, Utiger RD (1973) Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans. J Clin Invest 52:1616-1619
6. Bock JL, Wenz B, Gupta RK (1987) Studies on the mechanism of decreased NMR-measured free magnesium in stored erythrocytes. Biochim Biophys Acta 928:8-12
7. Bullock M, Lyeth B, Muizelaar J (1999) Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery 45:207-220
8. Dixon CE, Clifton GL, Lighthall JW, Yaghmai AA, Hayes RL (1991) A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods 39:253-262
9. Faden AI (1989) TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies. Brain Res 486:228-235
10. Faden AI (1993) Comparison of single and combination drug treatment strategies in experimental brain trauma. J Neurotrauma 10:91-100
11. Faden AI (1996a) Pharmacologic treatment of acute traumatic brain injury [editorial]. JAMA 276:569-570
12. Faden AI (1996b) Pharmacological treatment approaches for brain and spinal cord trauma. In: Neurotrauma (Narayan RK, Wilberger JE, Povlishock JT, eds), New York, NY: McGraw-Hill, pp 1479-1490
13. Faden AI (2001) Neuroprotection and traumatic brain injury: the search continues. Arch Neurol 58:1553-1555
14. Faden AI (2002) Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr Opin Neurol 15:702-712
15. Faden AI, Jacobs TP, Smith MT (1984) Thyrotropin-releasing hormone in experimental spinal injury: dose response and late treatment. Neurology 34:1280-1284
16. Faden AI, Sacksen I, Noble LJ (1988) Structure-activity relalionships of TRH analogs in rat spinal cord injury. Brain Res 448:287-293
17. Faden AI, Ellison JA, Noble LJ (1990) Effects of competitive and noncompetitive NMDA receptor antagonists in spinal cord injury. Eur J Pharmacol 175:165-174
18. Faden AI, Labroo VM, Cohen LA (1993) Imidazole-substituted analogues of TRH limit behavioral deficits after experimental brain trauma. J Neurotrauma 10:101-108
19. Faden AI, Fox GB, Fan L, Araldi GL, Qiao L, Wang S, Kozikowski AP (1999) Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents. Am J Physiol 277:R1196-R1204
20. Fox GB, Fan L, Levasseur RA, Faden AI (1998) Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouse. J Neurotrauma 15:599-614
21. 31P NMR. J Biol Chem 253:6172-6176
22. Hamm RJ, Dixon CE, Gbadebo DM, Singha AK, Jenkins LW, Lyeth BG, Hayes RL (1992) Cognitive deficits following traumatic brain injury produced by controlled cortical impact. J Neurotrauma 9:11-20
23. Kieffer JD, Weintraub BD, Baigelman W, Leeman S, Maloof F (1974) Homologous radioimmunoassay of thyrotrophin in rat plasma. Acta Endocrinol (Copenh) 76:495-505
24. Knoblach SM, Fan L, Faden AI (1999) Early neuronal expression of tumor necrosis factor-α after experimental brain injury contributes to neurological impairment. J Neuroimmunol 95:115-125
25. Koh JY, Wie MB, Gwag BJ, Sensi SL, Canzoniero LM, Demaro J, Csernansky C, Choi DW (1995) Staurosporine-induced neuronal apoptosis. Exp Neurol 135:153-159
26. Koskinen LO (1986) Effect of low intravenous doses of TRH, acid-TRH and cyclo(His-Pro) on cerebral and peripheral blood flows. Br J Pharmacol 87:509-519
27. Krause JF, McArthur DL, Silverman TA, Jayaraman M (1996) Epidemiology of brain injury. In: Neurotrauma (Narayan RK. Wilberger JE, Povlishock JT, eds). New York, NY: McGraw-Hill, pp 13-30
28. Maas AI (2001) Neuroprotoctive agents in traumatic brain injury. Expert Opin Invest Drugs 10:753-767
29. McIntosh TK, Noble L, Andrews B, Faden AI (1987) Traumatic brain injury in the rat: characterization of a midline fluid-percussion model. Cent Nerv Sys Trauma 4:119-134
30. 31P NMR studies. Am J Physiol 254:R785-R792
31. McIntosh TK, Vink R, Noble L, Yamakami I, Fernyak S, Soares H, Faden AI (1989) Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 28:233-244
32. McIntosh TK, Juhler M, Wieloch T (1998) Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998. J Neurotrauma 15:731-769
33. Metcalf G (1992) Regulatory peptides as a source of new drugs - the clinical prospects for analogues of TRH which are resistant to metabolic degradation. Brain Res 257:389-408
34. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60
35. Mukhin A, Fan L, Faden AI (1996) Activation of metabotropic glutamate receptor subtype mGluRI contributes to post-traumatic neuronal injury. J Neurosci 16:6012-6020
36. Mukhin AG, Ivanova SA, Knoblach SM, Faden AI (1997) New in vitro model of traumatic neuronal injury: evaluation of secondary injury and glutamate receptor-mediated neurotoxicity. J Neurotrauma 14:651-663
37. Mukhin AG, Ivanova SA, Allen JW, Faden AI (1998) Mechanical injury to neuronal/glial cultures in microplates: role of NMDA receptors and pH in secondary neuronal cell death. J Neurosci Res 51:748-758
38. Olson GL, Cheung HC, Chiang E, Madison VS, Sepinwall J, Vincent GP, Winokur A, Gary KA (1995) Peptide mimetics of thyrotropin-releasing hormone based on a cyclohexane framework: design, synthesis, and cognition-enhancing properties. J Med Chem 38:2866-2879
39. Pitts LH, Ross A, Chase GA, Faden AI (1995) Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries. J Neurotrauma 12:235-243
40. Pohl D, Bittigau P, Ishimaru MJ, Stadthaus D, Hubner C, Olney JW, Turski L, Ikowmidou C (1999) N-Methyl-D-asparate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A 96:2508-2513
41. Povlishock JT (1996) An overview of brain injury models. In: Neurotrauma (Narayan RK, Wilberger JE, Povlishock JT, eds). NewYork. NY: McGraw-Hill, pp 1325-1336
42. Prasad C (1995) Bioactive cyclic dipeptides. Peptides 16:151-164
43. Raghupathi R, Graham DI, McIntosh TK (2000) Apoptosis after traumatic brain injury. J Neurotrauma 17:927-938
44. Shvachkin IP, Korshunova GA, Bavykina NI, Guliaeva NV, Dupin AM (1989) The antioxidant activity of cyclohistidylproline. Biull Eksp Biol Med 108:671-673
45. Siesjo BK (1981) Measurements of cerebral oxygen consumption: advantages and limitations. Eur Neurol 20:194-199
46. Smith DH, Soares HD, Pierce JS, Perlman KG, Saatman KE, Meaney DF, Dixon CE, McIntosh TK (1995) A model of parasagittal controlled cortical impact in the mouse: cognitive and histopathologic effects. J Neurotrauma 12:169-178
47. Veech RL, Lawson JW, Cornell NW, Krebs HA (1979) Cylosolic phosphorylation potential. J Biol Chem 254:6538-6547
48. 31P magnetic resonance spectroscopy study. J Cereb Blood Flow Metab 7:563-571
49. Vink R, McIntosh TK, Faden AI (1988) Treatment with the thyrotropin-releasing hormone analog CG3703 restores magnesium homeostasis following traumatic brain injury in rats. Brain Res 460:184-188
50. 2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats. J Neurosci 10:3524-3530
51. Vink R, Golding EM, Headrick JP (1994) Bioenergetic analysis of oxidative metabolism following traumatic brain injury in rats. J Neurotrauma 11:265-274
52. Vink R, Heath DL, McIntosh TK (1996) Acute and prolonged alterations in brain free magnesium following fluid percussion-induced brain trauma in rats. J Neurochem 66:2477-2483
53. Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AI (1997) Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 17:7415-7424
54. Yamakami I, Vink R, Faden AI, Gennarelli TA, Lenkinski R, McIntosh TK ((1995) Effects of acute ethanol intoxication on experimental brain injury in the rat: neurobehavioral and phosphorus-31 nuclear magnetic resonance spectroscopy studies. J Neurosurg 82:813-821
55. Zhao X, Pike BR, Newcomb JK, Wang KK, Posmantur RM, Hayes RL (1999) Maitotoxin induces calpain but not caspase-3 activation and necrotic cell death in primary septo-hippocampal cultures. Neurochem Res 24:371-382